Amgen and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP [nasal polyps]). The trial ...

A family history of cystic fibrosis may be present but doesn’t have to be, so signs to look for include poor weight gain, sinusitis, nasal polyps ... one in 20,000 live births and involves ...

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in ... vice chair of Rhinology & Endoscopic Sinus and Skull ...

In some cases, surgery may be necessary to remove large or obstructive polyps. If you experience persistent nasal congestion, a reduced sense of smell, or symptoms associated with any of these ...

Sometimes they may recommend surgery to remove nasal polyps. Getting treatment is important for limiting symptoms and preventing complications. However, it is possible for nasal polyps to return ...

These patients have high corticosteroid exposure and often experience recurrence of nasal polyps following surgery. We’re very encouraged by the results from the ANCHOR studies, which ...

Biologic drugs are a newer treatment option for chronic rhinosinusitis with nasal polyps. They work differently from other treatments. Nasal polyps are small, noncancerous growths that develop in ...

“These patients have high corticosteroid exposure and often experience recurrence of nasal polyps following surgery.” “We're very encouraged by the results from the ANCHOR studies, which ...

The study's co-primary endpoints were to see the change from baseline in total endoscopic nasal polyp score at 52 weeks and the change from baseline in mean nasal obstruction score from weeks 49 ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps ... after surgery and systemic ...